Thermo Fisher Scientific Launches CE-IVD (IVDD) Next-Generation Sequencing Test and Analysis Software to Expand Access to Precision Oncology Biomarker Testing
Oncomine Precision Assay receives breakthrough device designation by the US FDA - Express Pharma
Thermo Fisher wins FDA OK of Oncomine Dx Target test to aid in cancer therapy selection | Seeking Alpha
Thermo Fisher Scientific Introduces Oncomine Clinical Research Grant Program to Support Oncology and Reproductive Health Studies | Today's Clinical Lab